88 results
Page 2 of 5
8-K
EX-99.1
ijkjlk0w qsbum
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
f7p1md61gr7q0
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
uufnzhe
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
ere3 8pnw4a
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
8-K
EX-99.1
8zgaaj9 llyj9gw3x
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
8-K
EX-99.1
k9tmgvtcbqpeth
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
6iqhnlpruwbz3
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.3
lmh3zwo4hv0po2e a3
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.2
z3m nys5z9zxy94vin6
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
hpshdxa s68cvmqzd
22 Nov 19
Other Events
5:01pm
8-K
EX-99.1
b0n1wvl
22 Nov 19
Other Events
5:01pm
8-K
EX-99.1
reb5gsy6
31 Oct 19
Agios Reports Business Highlights and Third Quarter 2019 Financial Results
7:39am
8-K
EX-99.1
0qpzrqik5tb20ralw
30 Sep 19
Other Events
11:13am
8-K
r9veso0obtdo1usl38bn
30 Sep 19
Other Events
11:13am
8-K
EX-99.1
7nemvv
1 Aug 19
Agios Reports Business Highlights and Second Quarter 2019 Financial Results
7:29am
8-K
EX-99.1
q9q7lzrrpr4zrcj8 k9
3 Jun 19
Other Events
4:02pm
8-K
53rrfok
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
udat19e0jft5 4p4i5wr
15 May 19
Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma
4:13pm
8-K
EX-99.1
y2846o 41vgk03
2 May 19
Other Events
3:24pm